Induction maintenance concept for HAART as initial treatment in HIV infected infants

<p>Abstract</p> <p>Background</p> <p>Early initiated antiretroviral therapy (ART) in HIV infected infants leads to improved long-term viral suppression and survival. Guidelines recommend initiating therapy with a triple ART consisting of two nucleoside reverse transcrip...

Full description

Bibliographic Details
Main Authors: Ghosh S, Neubert J, Niehues T, Adams O, Morali-Karzei N, Borkhardt A, Laws HJ
Format: Article
Language:English
Published: BMC 2011-06-01
Series:European Journal of Medical Research
Subjects:
Online Access:http://www.eurjmedres.com/content/16/6/243
_version_ 1818806196521402368
author Ghosh S
Neubert J
Niehues T
Adams O
Morali-Karzei N
Borkhardt A
Laws HJ
author_facet Ghosh S
Neubert J
Niehues T
Adams O
Morali-Karzei N
Borkhardt A
Laws HJ
author_sort Ghosh S
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Early initiated antiretroviral therapy (ART) in HIV infected infants leads to improved long-term viral suppression and survival. Guidelines recommend initiating therapy with a triple ART consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) and either one additional non-nucleoside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI). Compared to older children and adults, viral relapse is seen more frequently in infants receiving triple ART. We now address the possibility of a more potent ART with a quadruple induction and triple maintenance therapy.</p> <p>Methods</p> <p>We examine the longitudinal course in four HIV infected infants, who were referred from other centers and could not be recruited to multicentre trials. We introduced ART initially consisting of two NRTIs, one NNRTI and one PI and later discontinued the PI at the age of 12 months maintaining a triple regime consisting of two NRTIs and one NNRTI.</p> <p>Results</p> <p>Provided that therapy adherence was maintained we observed an effective sustained decline of viral load and significant CD4 cell reconstitution even after switching to a triple regime. No drug associated toxicity was seen.</p> <p>Conclusion</p> <p>We suggest that a four drug therapy might be a possible initial therapy option in HIV infected infants, at least in those with a high viral load, followed by a maintenance triple regime after 12 months of therapy.</p>
first_indexed 2024-12-18T19:05:56Z
format Article
id doaj.art-771b0961e573466299086bc5e6cea9f1
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-12-18T19:05:56Z
publishDate 2011-06-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-771b0961e573466299086bc5e6cea9f12022-12-21T20:56:24ZengBMCEuropean Journal of Medical Research2047-783X2011-06-0116624310.1186/2047-783X-16-6-243Induction maintenance concept for HAART as initial treatment in HIV infected infantsGhosh SNeubert JNiehues TAdams OMorali-Karzei NBorkhardt ALaws HJ<p>Abstract</p> <p>Background</p> <p>Early initiated antiretroviral therapy (ART) in HIV infected infants leads to improved long-term viral suppression and survival. Guidelines recommend initiating therapy with a triple ART consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) and either one additional non-nucleoside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI). Compared to older children and adults, viral relapse is seen more frequently in infants receiving triple ART. We now address the possibility of a more potent ART with a quadruple induction and triple maintenance therapy.</p> <p>Methods</p> <p>We examine the longitudinal course in four HIV infected infants, who were referred from other centers and could not be recruited to multicentre trials. We introduced ART initially consisting of two NRTIs, one NNRTI and one PI and later discontinued the PI at the age of 12 months maintaining a triple regime consisting of two NRTIs and one NNRTI.</p> <p>Results</p> <p>Provided that therapy adherence was maintained we observed an effective sustained decline of viral load and significant CD4 cell reconstitution even after switching to a triple regime. No drug associated toxicity was seen.</p> <p>Conclusion</p> <p>We suggest that a four drug therapy might be a possible initial therapy option in HIV infected infants, at least in those with a high viral load, followed by a maintenance triple regime after 12 months of therapy.</p>http://www.eurjmedres.com/content/16/6/243HIVHAARTanti HIV agentsinfantsviral load
spellingShingle Ghosh S
Neubert J
Niehues T
Adams O
Morali-Karzei N
Borkhardt A
Laws HJ
Induction maintenance concept for HAART as initial treatment in HIV infected infants
European Journal of Medical Research
HIV
HAART
anti HIV agents
infants
viral load
title Induction maintenance concept for HAART as initial treatment in HIV infected infants
title_full Induction maintenance concept for HAART as initial treatment in HIV infected infants
title_fullStr Induction maintenance concept for HAART as initial treatment in HIV infected infants
title_full_unstemmed Induction maintenance concept for HAART as initial treatment in HIV infected infants
title_short Induction maintenance concept for HAART as initial treatment in HIV infected infants
title_sort induction maintenance concept for haart as initial treatment in hiv infected infants
topic HIV
HAART
anti HIV agents
infants
viral load
url http://www.eurjmedres.com/content/16/6/243
work_keys_str_mv AT ghoshs inductionmaintenanceconceptforhaartasinitialtreatmentinhivinfectedinfants
AT neubertj inductionmaintenanceconceptforhaartasinitialtreatmentinhivinfectedinfants
AT niehuest inductionmaintenanceconceptforhaartasinitialtreatmentinhivinfectedinfants
AT adamso inductionmaintenanceconceptforhaartasinitialtreatmentinhivinfectedinfants
AT moralikarzein inductionmaintenanceconceptforhaartasinitialtreatmentinhivinfectedinfants
AT borkhardta inductionmaintenanceconceptforhaartasinitialtreatmentinhivinfectedinfants
AT lawshj inductionmaintenanceconceptforhaartasinitialtreatmentinhivinfectedinfants